By continuing to use the site, you will be treated as having given your consent for processing your personal data: cookies and user data using the Yandex.Metrika and liveinternet.ru metric programs to improve the site and for the purpose of statistical analysis. If you do not want your data to be processed, please leave the site
RU
Media
“Biosintez” Penza
All videos
01:44
min
Articles
27 февраля 2022
Newspaper "Фармацевтический Вестник", №7, 2021
27 февраля 2022
ПАО «Биосинтез» successfully completed testing of a new drug
26 февраля 2022
Newspaper "Фармацевтический Вестник", №20, 2021
26 февраля 2022
ПАО «Биосинтез» launched the production of a combined antidiabetic drug
25 февраля 2022
Journal "Предпринимательство в лицах", april 2021
25 февраля 2022
ПАО "Биосинтез" received a commendation for the development of exports
24 февраля 2022
Journal "Ремедиум Приволжье", №5, 2017
24 февраля 2022
ПАО "Биосинтез" took part in the conference of manufacturers of medicines
23 февраля 2022
Newspaper "Фармацевтический Вестник", №4, 2020
23 февраля 2022
The Ministry of Industry and Trade of the Russian Federation noted the work of the employees of ПАО "Биосинтез"

News
27 мая 2022
Chemist’s Day
Today, as part of the Chemist's Day celebration, the Company held an award ceremony for its employees.
More detailed
29 апреля 2022
Meeting with students
On March 23, Penza State University (PSU) hosted a large-scale meeting of our company with students of specialties of the Medical, Pedagogical and Polytechnic Institutes as part of the Career Day at PJSC “Biosintez”.
More detailed
18 февраля 2022
Biosintez launched production of a combined antidiabetic drug
The drug contains two ingredients: glibenclamide and metformin. * Metformin and glibenclamide differ in mechanisms of action and complement each other's hypoglycemic activity.
More detailed
All news
Карьерное сотрудничество 9